NCT05270135View on ClinicalTrials.gov

ASAP: Access to Syringes at Pharmacies for the Prevention of Bloodborne Infections Among People Who Inject Drugs

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

December 1, 2022

Primary Completion Date

June 30, 2023

Study Completion Date

September 30, 2023

Conditions
Skin and Soft Tissue InfectionsHivHepatitis CBloodstream Infection
Interventions
BEHAVIORAL

ASAP

ASAP is an intervention geared toward increasing non-stigmatized syringe sales to people who inject drugs to prevent bloodborne illnesses.

Trial Locations (1)

85714

University of Arizona College of Medicine, Tucson

All Listed Sponsors
lead

University of Arizona

OTHER